Literature DB >> 32093961

Electrical cardioversion for atrial fibrillation in the emergency department: A large single-center experience.

Andrew M Fried1, Tania D Strout2, Andrew D Perron3.   

Abstract

OBJECTIVE: Electrical cardioversion of ED patients is a well-described treatment strategy for certain patients presenting with atrial fibrillation (AF). The objective of this study was to describe the safety and outcomes of this practice in a cohort of patients undergoing ED electrical cardioversion for AF.
METHODS: This retrospective health records survey investigated a 5-year cohort of consecutive ED patients presenting with AF who underwent electrical cardioversion in an academic, tertiary ED. Electronic and manual abstraction strategies were used, extracting data on demographics, clinical features, interventions, complications, and return visits within 1 month. Data were analyzed using descriptive statistics and agreement between trained abstractors on key variables was excellent (k = 0.94-0.98).
RESULTS: Data from 887 patients were analyzed. Electrical cardioversion was successful in 781 (88%) encounters. There were 3 major complications (3/887; 0.3%) and 123 minor complications (123/887; 14%). Major complications included one post-cardioversion stroke (1/887; 0.1%), one jaw thrust maneuver for hypoxia (0.1%), and one overnight observation for hypotension (0.1%). 741 patients (84%) were discharged following cardioversion with a mean ED LOS of 218 min (95% CI: 206-231 min). 57 (6.4%) patients returned to the ED within 30 days; 43 (4.8%) returned with in AF or flutter.
CONCLUSIONS: In this cohort of ED patients with atrial fibrillation, ED electrical cardioversion followed by discharge to home was largely safe and effective. Most complications were transient and mild. There were remarkably few serious complications.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Cardioversion; Complications; Emergency department; Safety

Mesh:

Year:  2020        PMID: 32093961     DOI: 10.1016/j.ajem.2020.02.001

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  4 in total

1.  Efficacy and safety of vernakalant for cardioversion of recent-onset atrial fibrillation: A protocol for systematic review and meta-analysis.

Authors:  Hong Li; Yi Liang; Xuejing Song; Wu-Sha Liu-Huo; Wen Chen; Chao Tang; Lizhi Zhao; Xue Bai
Journal:  Medicine (Baltimore)       Date:  2022-03-11       Impact factor: 1.817

2.  Efficacy of Electrical Cardioversion in Relation to Occurrence and Type of Functional Mitral Regurgitation in Patients with Atrial Fibrillation.

Authors:  Konrad Klocek; Katarzyna Klimek; Michał Tworek; Karolina Wrona-Kolasa; Małgorzata Cichoń; Maciej Wybraniec; Katarzyna Mizia-Stec
Journal:  J Clin Med       Date:  2022-04-07       Impact factor: 4.964

3.  Multi-scale Entropy Evaluates the Proarrhythmic Condition of Persistent Atrial Fibrillation Patients Predicting Early Failure of Electrical Cardioversion.

Authors:  Eva María Cirugeda Roldan; Sofía Calero; Víctor Manuel Hidalgo; José Enero; José Joaquín Rieta; Raúl Alcaraz
Journal:  Entropy (Basel)       Date:  2020-07-07       Impact factor: 2.524

4.  The Impact of Personal Thoracic Impedance on Electrical Cardioversion in Patients with Atrial Arrhythmias.

Authors:  Seung-Young Roh; Jinhee Ahn; Kwang-No Lee; Yong-Soo Baek; Dong-Hyeok Kim; Dae-In Lee; Jaemin Shim; Jong-Il Choi; Young-Hoon Kim
Journal:  Medicina (Kaunas)       Date:  2021-06-13       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.